Press Releases

Mithra to Host Webcast for Half Year Financial Results on 24 September 2021
17 September 2021
EN FR

Mithra Announces Estelle® Approval in Russia
16 September 2021
EN FR

Mithra and Searchlight Pharma Announce Availability of Nextstellis® in Pharmacies Across Canada
15 September 2021
EN FR

Mithra extends the pricing period for the put option announced on July 2, 2021 under the agreement with LDA Capital
13 August 2021
EN FR

ExeVir and Mithra announce manufacturing collaboration for innovative Covid-19 treatments
15 July 2021
EN FR

Mithra Issues a Put Option Notice Under Capital Agreement with LDA Capital
2 July 2021
EN FR

Mithra successfully renegotiates the earnouts relating to its Complex Therapeutics and acquires full licensing and distribution rights for Zoreline®
24 June 2021
EN FR

Estelle® Oral Contraceptive Now Available In The United States
21 June 2021
EN FR

Mithra Completes Recruitment of Covid-19 Phase II Study
17 June 2021
EN FR

Nextstellis® Receives FDA Marketing Exclusivity and Phase III Data Published
27 May 2021
EN FR

Mithra Announces European Approval of Estelle®
20 May 2021
EN FR

Mithra’s General Meeting of Shareholders Approves the Renewal of its Board of Directors
20 May 2021
EN FR